Genvax Technologies, Inc. is a dynamic startup animal vaccine company based in Ames, Iowa, specializing in the development of next-generation mRNA nanoparticle vaccines for the prevention and treatment of animal diseases.
With a team of experienced scientists and entrepreneurs, Genvax Technologies aims to create breakthrough solutions that have a long-lasting impact on animal health worldwide, building on the success of its co-founders who previously established and sold Harrisvaccines to Merck Animal Health.
Generated from the website